Citius Oncology (CTOR) Treasury Shares (2022 - 2024)

Citius Oncology (CTOR) has 3 years of Treasury Shares data on file, last reported at $4.3 million in Q2 2024.

• On a quarterly basis, Treasury Shares fell 34.67% year-over-year to $4.3 million in Q2 2024; TTM through Jun 2024 was $4.3 million, a 34.67% decrease from a year earlier, with the FY2023 full-year figure at $6.6 million, changed 0.0% from the prior year.
• Treasury Shares for Q2 2024 stood at $4.3 million, roughly flat from $4.3 million in the prior quarter.
• Over the last five years, Treasury Shares for CTOR reached as high as $6.6 million in Q4 2022 and fell as low as $4.3 million in Q1 2024.
• Historically, Treasury Shares has averaged $5.9 million across 3 years, with a median of $6.6 million in 2022.
• Across the five-year window, Treasury Shares changed 0.0% in 2023 and slumped 34.67% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $6.6 million in 2022, then changed by 0.0% to $6.6 million in 2023, then slumped by 34.67% to $4.3 million in 2024.
• Per Business Quant data, the three most recent Treasury Shares figures were $4.3 million in Q2 2024, $4.3 million in Q1 2024, and $6.6 million in Q4 2023.